In the specialized field of biochemical research, the RGDS peptide—a tetrapeptide sequence consisting of Arginyl-glycyl-aspartyl-serine (Arg-Gly-Asp-Ser)—serves as a critical tool for studying cellular interactions. As someone who has spent considerable time exploring laboratory-grade biochemical reagents, I have found that understanding the specific interplay between synthetic peptides and cellular matrices is essential for any rigorous investigative work.
The Biochemical Profile of RGDS
At its core, the peptide RGDS is recognized as a synthetic cell adhesion factor. It functions primarily as an integrin-binding sequence. In many experimental models, RGDS is utilized because it acts as an inhibitor of integrin receptor function. By mimicking the cell attachment site found in proteins like fibronectin, this tetra-peptide allows researchers to modulate how cells interact with their surrounding environment.
From a structural perspective, the RGDS peptide (CAS 91037-65-9) has a molecular weight of approximately 433.42 Da. When sourcing this material for laboratory use, purity is paramount; high-quality samples typically exhibit a purity of RGDS peptide is an integrin binding sequence that inhibits integrin receptor function. Decreases systemic inflammation via inhibition of collagen-triggered >95%, often confirmed via NMR and HPLC analysis. It is important to reiterate that this is a laboratory product for research use only and is strictly not for personal consumption.
Mechanisms and Research Applications
The scientific literature frequently highlights that RGDS peptide is a fibronectin inhibitor. Because it is an inhibitor of the binding of integrins to the extracellular matrix (ECM), it serves as a powerful instrument for dissecting signaling pathways.
Some of the most compelling research involves its use in:
* Integrin-Mediated Signaling: RGD peptides are used to study cell adhesion mechanisms and integrin signaling pathways, providing a window into how cells sense their mechanical environment.
* Targeting and Modulation: Research has shown that RGD peptides can be utilized to specifically target cancer cells and tumor vasculature by engaging with specific integrins. Furthermore, studies have demonstrated that RGDS inhibits melanoma by H Javid · 2024 · Cited by 248 — RGD peptides can be utilized to specifically target cancer cells and the tumor vasculature by engaging with these integrins, improving drug delivery efficiency. growth through an adhesion-independent mechanism, potentially by interacting with intracellular survivin.
* Inflammatory Response Studies: In specific pulmonary models, a synthetic RGDS peptide can be used to inhibit pulmonary inflammatory responses by mitigating the effects of lipopolysaccharides (LPS).
Understanding the RGD Motif
While the RGDS tetrapeptide is specific, it is part of a broader family of RGD (Arg-Gly-Asp) peptides. The RGD motif is a cell adhesion sequence that binds to integrins, which are a receptor family for extracellular matrix proteins. Whether working with a simple tripeptide or a more complex RGD-containing peptide, the goal is often the same: to bridge inert laboratory materials with ECM-like functionality.
For instance, some variants are designed to include a thiol group on the N-terminus, allowing the peptide to be immobilized on thiol-reactive polymers. This is particularly useful in hydrogel preparation and tissue engineering, where directing the association of vario The integrin-blocking peptide RGDS inhibits airway smooth muscle remodeling in a guinea pig model of allergic asthma. us cell types with diverse biomaterials is a primary ob RGD peptide (Arg-Gly-Asp) | Tripeptide | CAS 99896-85-2 jective.
Essential Considerations for Researchers
When integrating these compounds into your studies, it is vital to keep the following in mind:
1. Specificity: Always distinguish betwe Synthetic RGDS peptide attenuates lipopolysaccharide en the shorter RGD sequences and the specific RGDS tetrapeptide. Their inhibitory pro RGDS peptide inhibits thrombin-induced binding of platelets to fibronectin, fibrinogen α, and von Willebrand factor with IC50 value of 10 μM. files against various ligands—such as fibrinogen, von Willebrand factor, and fibronectin—can differ significantly.
2. Experimental Control: Because Arg-G RGDS peptide is an integrin binding sequence that inhibits integrin receptor function. Decreases systemic inflammation via inhibition of collagen-triggered ly-Asp-Ser is an integrin-binding sequence that inhibits integrin receptor function, it is essential to use appropriate negative controls to ensure RGDS peptide inhibits thrombin-induced binding of platelets to fibronectin, fibrinogen α, and von Willebrand factor with IC50 value of 10 μM. that observed effects are truly due to the interruption of cell-matrix signaling.
3. Safety and Handling: Always treat these substances as professional reagents. They a RGDS peptide (Arg-Gly-Asp-Ser, Fibronectin tetrapeptide) re fibronectin-derived, integrin-binding peptides meant for controlled environments. Any suggestion of personal use is both scientifically unfounded and dangerous; these compounds are strictly for *in vitro* or *in vivo* animal research models.
By maintaining high standards of reagent purity and focusing on the well-documented mechanisms of the RGD sequence (which characterizes sites for integrin-mediated cell adhesion), researchers can continue to unlock the complexities of cell biology. The RGDS peptide remains a foundational tool in this pursuit, offering a reliable way to mimic and modulate the natural signals that govern cellular behavior.